-transparent.png){kind=logo}
Patients with prednisone-resistant nephrotic syndrome and biopsy-proven focal segmental glomerulosclerosis were treated with intravenous methylprednisone. After the first 2 weeks of therapy, the average urine protein excretion decreased from 247 to 96 mg/m2/h (p less than 0.04). Two of the 7 patients have had long-term, nearly complete remissions. The other patients relapsed. One relapsing patient was retreated with methylprednisolone and is now in remission. Four relapsing patients were treated with alkylating agents, in combination with methylprednisolone. All of these patients entered complete or partial remissions. Methylprednisolone causes a significant decrease in the proteinuria of children with focal segmental glomerulosclerosis. In addition, although the follow-up period is relatively short, it would appear that methylprednisolone, often in conjunction with an alkylating agent, has significantly improved the clinical status of these patients.
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
December 2006,
Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
February 1983,
The Journal of pediatrics,
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
June 1998,
Pediatric nephrology (Berlin, Germany),
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
April 1981,
The Journal of pediatrics,
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
January 1999,
Pediatric nephrology (Berlin, Germany),
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
May 2018,
Clinical nephrology,
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
January 2008,
Paediatric drugs,
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
September 2022,
Kidney international reports,
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
July 1986,
The Journal of pediatrics,
W R Griswold, and
B M Tune, and
V M Reznik, and
M Vazquez, and
D J Prime, and
P Brock, and
S A Mendoza
January 1990,
American journal of nephrology,
